Medical Minute: Influence of Anxiety and Depression on MS and Associated Symptoms

Review the clinical implications of anxiety and depression for patients with MS and guideline-based recommendations for proper diagnosis and treatment.
Patricia K. Coyle, MD, FAAN, FANA
Patricia Melville, ANP-BC, MSCN
Format: Microsoft PowerPoint (.ppt)
File Size: 430 KB
Released: August 26, 2021

Acknowledgements

Provided by Consortium of Multiple Sclerosis Centers (CMSC), in collaboration with Clinical Care Options

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Biogen
Bristol-Myers Squibb

Related Content

Slides from a presentation that educates clinicians on novel and emerging treatments for myasthenia gravis

person default Jonathan Katz, MD Gil Wolfe, MD, FAAN Released: September 23, 2022

Slides from a presentation that educates clinicians on new and emerging treatments for treating neuropsychiatric symptoms in Alzheimer’s disease dementia.

Marwan Sabbagh, MD, FAAN Released: September 19, 2022

Slides from a presentation that educates clinicians on managing major depression.

Manish Jha, MD Vladimir Maletic, MD Greg W. Mattingly, MD Released: August 30, 2022

Read about a patient’s experience with bipolar disorder and reaching recovery, from Clinical Care Options (CCO)

person default Katherine Ponte, JD, MBA, CPRP Released: August 12, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings